Search
ETC-1001
go.drugbank.com/drugs/DB05866ExperimentalETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Denibulin
go.drugbank.com/drugs/DB05932ExperimentalDenibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Aminacrine
go.drugbank.com/drugs/DB11561InvestigationalA highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.
3,3'-diindolylmethane
go.drugbank.com/drugs/DB11875InvestigationalDiindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others.
Famitinib
go.drugbank.com/drugs/DB11741InvestigationalFamitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others
Cenicriviroc
go.drugbank.com/drugs/DB11758InvestigationalCenicriviroc has been used in trials studying the treatment of HIV-infection/AIDS, AIDS Dementia Complex, Nonalcoholic Steatohepatitis, Human Immunodeficiency Virus, and HIV-1-Associated Cognitive Motor
Afacifenacin
go.drugbank.com/drugs/DB21385ExperimentalAfacifenacin has a monoisotopic molecular weight of 481.2 Da.
Fosifidancitinib
go.drugbank.com/drugs/DB21462ExperimentalFosifidancitinib has a monoisotopic molecular weight of 505.12 Da.
Gemnelatinib
go.drugbank.com/drugs/DB21513ExperimentalGemnelatinib has a monoisotopic molecular weight of 524.23 Da.
Girocitinib
go.drugbank.com/drugs/DB21692ExperimentalGirocitinib has a monoisotopic molecular weight of 326.14 Da.